IHC CD1a Test for Melanoma | Lahalak Medical Platform
A specialized histological analysis detecting CD1a protein to accurately diagnose melanoma and rare immune disorders, providing clinicians with a precise roadmap for effective and personalized treatment strategies.
Scientific name: Immunohistochemistry (IHC) for CD1a
Immunohistochemistry (IHC) for the CD1a marker is a histological analysis aimed at detecting and locating the CD1a protein on cell membranes. This marker is primarily used to identify Langerhans cells in conditions like Langerhans Cell Histiocytosis, to evaluate some T-cell lymphomas, and in some thymic tumors.
Service type
Laboratory Tissue Analysis
Duration
15-20 minutes
Fasting
Fasting is not required
Included Services
- Accurate tissue diagnosis using the CD1a marker
- Consultation and interpretation of results with a pathologist
- Personal support services from Lehlek
Medical Service Information
Conditions & Notices
- Fasting is not required, as the sample needed is a tissue sample (biopsy), not a blood sample.
- The biopsy sample must be properly preserved and processed (usually in formalin and paraffin).
- A clear medical report including the expected differential diagnosis should be included with the sample to guide the investigation.
- The analysis may take longer than routine tests due to the complex histological processing steps.
Medical services you might also like
